| Bioactivity | RIPK1-IN-28 (compound 13) is an orally active RIPK1 inhibitor. RIPK1-IN-28 inhibits human I2.1 and Hepa1‐6 cells with IC50s of 0.4 and 1.2 nM, respectively[1]. |
| CAS | 2968509-28-4 |
| Formula | C27H24N4O4 |
| Molar Mass | 468.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. An Y, et al. Design and synthesis of pyridazin-4-one derivatives as necroptosis inhibitors. Arch Pharm (Weinheim). 2025 Jan;358(1):e2400594. |
RIPK1-IN-28
CAS: 2968509-28-4 F: C27H24N4O4 W: 468.50
RIPK1-IN-28 (compound 13) is an orally active RIPK1 inhibitor. RIPK1-IN-28 inhibits human I2.1 and Hepa1‐6 cells with I
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.